| Award Mechanism |
Eligibility |
Key Mechanism Elements |
Funding |
| Idea Development Award |
Independent investigator at or above the level of Assistant Professor (or equivalent) |
- Supports innovative approaches to prostate cancer research that may include high risk, provided there is
potential for significant impact
- Emphasis is on innovation and impact
- Preliminary data are encouraged but not required
- NEW: Applications must address one or more of the FY09 Focus Areas: Imaging,
Biomarkers, Therapy, Genetics, Tumor Biology, and Survivorship
- NEW: Preproposal is required; application submission is by invitation only
- Clinical trials are not permitted
|
- Maximum funding of $450K for direct costs (plus indirect costs)
- Period of performance cannot exceed 3 years
|
| Population-Based Idea Development Award (NEW!) |
Independent investigator at or above the level of Assistant Professor (or equivalent) |
- Supports innovative, high-impact approaches to prostate cancer research that can be achieved from the
perspective of population-based studies; approaches may include high risk, provided there is potential for
significant impact
- Emphasis is on innovation and impact
- Areas of population-based studies include but are not limited to population genomics, meta-analysis,
prospective and/or retrospective analyses, diet and exercise, survival, population surveillance with specific
relevance to prostate cancer
- Preliminary data are encouraged but not required
- Clinical trials are not permitted
|
- Maximum funding of $600K for direct costs (plus indirect costs)
- Period of performance cannot exceed 4 years
|
| Synergistic Idea Development Award |
Investigators at or above the level of Assistant Professor (or equivalent) |
- Supports new or existing partnerships between two or three independent investigators to address a central
innovative question in prostate cancer that may include high risk, provided there is a potential for
significant impact
- Emphasis is on synergy, innovation, and impact
- Preliminary data are encouraged but not required
- NEW: Applications must address one or more of the FY09 Focus Areas: Imaging, Biomarkers, Therapy,
Genetics, Tumor Biology, and Survivorship
- NEW: Preproposal is required; application submission is by invitation only
- Clinical trials are not permitted
|
- Maximum funding of $750K for direct costs (plus indirect costs)
- Period of performance cannot exceed 3 years
|
| New Investigator Award |
Independent investigators with institutional support who, at the time of submission:
- Are within 3 years of first independent faculty position;and
- Have sufficient skills and knowledge to function independently without mentorship;and
- Can provide evidence of institutional support such as start-up funds, space, resources, etc.
|
- Supports early-career investigators with innovative, high-impact ideas or new technologies relevant to
prostate cancer
- PIs must name a Collaborator with a proven record in prostate cancer research
- Emphasis is on PI and Collaborator, innovation, and impact
- Preliminary data are not required
- NEW: Applications must address one or more of the FY09 Focus Areas: Imaging, Biomarkers, Therapy,
Genetics, Tumor Biology, and Survivorship
- Clinical trials are not permitted
|
- Maximum funding of $225K for direct costs (plus indirect costs)
- Period of performance cannot exceed 3 years
|
| Prostate Cancer Pathology Resource Network (NEW!) |
Independent investigators at or above the level of Assistant Professor
(or equivalent) |
- Supports the development of a consortium infrastructure that will facilitate prostate cancer research
through the collection, processing, annotation, storage, and distribution of human biospecimens in a
collaborative fashion across multiple institutions
- Each proposal must include one Coordinating Center and two Pathology Resource Sites to be jointly
responsible for development of the biospecimen repository for prostate cancer research
- Sites must provide plans for biospecimen collection, processing, annotation, storage, distribution,
quality assurance, bioinformatics and data management, ethical and regulatory issues, and plans for
acquiring samples from populations disproportionately affected by prostate cancer
- Encourages submissions from investigators with enhanced skills in human biospecimen procurement, human
tissue repositories, distribution, and working within a collaborative consortium-type network of multiple
institutions
- Consortium is expected to provide a plan to achieve financial self-sufficiency such that operations can
continue after the award ends
|
- Maximum funding of $2.5M for direct costs (plus indirect costs)
- Period of performance cannot exceed 3 years
- Funds may not be used for laboratory or clinical research
|
| Health Disparity Research Award |
PIs may apply for only one of the following categories:
Transitioning Investigators:
Must hold Ph.D. and/or M.D.; and
- Must have received no more than $300,000 in direct costs in aggregate as a PI or
co-PI of a federally or privately funded, non-mentored peer-reviewed grant; and
- At the time of proposal submission, must either:
- Have documentation of receipt of their first independent faculty appointment (or equivalent);
or
- Be within 3 years of having started their first independent faculty position
(or equivalent)
Early-Career Investigators:
Independent investigators who are, at the time of proposal submission:
- Within 3 years of first independent faculty position; and
- Have sufficient skills and knowledge to function independently without mentorship; and
- Can provide evidence of institutional support such as start-up funds, space, resources, etc.
Established Investigator PIs:
Independent investigator at or above the level of Assistant Professor (or equivalent)
|
- Supports prostate cancer health disparity-focused projects by investigators at multiple points in their
careers
- PI or collaborator(s) should have a connection to, or effectiveness in working with, an affected
population or community
- For Transitioning and Early-Career Investigators, institution must provide 50% protection of PI's time
for research
- Designatedmentor with experience in prostate cancer health disparity research
required for Transitioning Investigator Awards
- Collaborator with experience in prostate cancer health disparity research
required for Early-Career Investigator Awards
- NEW: Applications must address one or more of the FY09 Focus Areas: Imaging,
Biomarkers, Therapy, Genetics, Tumor Biology, and Survivorship
|
- Transitioning Investigators: Maximum funding of $225K for direct costs (plus indirect
costs)
- Early-Career Investigators: Maximum funding of $225K for direct costs (plus indirect
costs)
- Established Investigators: Maximum funding of $450K for direct costs (plus indirect
costs)
- Period of performance cannot exceed 3 years for all three categories
|
| Health Disparity Training Award |
Predoctoral Ph.D. and M.D./Ph.D. PIs:
- Must be enrolled full-time in an accredited doctoral program and must have completed all predissertation
requirements by October 1, 2009
Postdoctoral Ph.D. PIs:
- Must have successfully defended a doctoral thesis by October 1, 2009; and
- Have 3 years or less of postdoctoral fellowship experience by October 1, 2009
Postdoctoral M.D. PIs:
- Must have an M.D.; and
- Must be able to devote at least 40% effort; and
- By August 1, 2009, must be:
- Enrolled in an accredited intern, residency, or fellowship training program, or
- Within 3 years of the last formal training
|
- Supports training in prostate cancer disparity research for individuals in the early stages of their
careers
- PIs must have a designated mentor who is an experienced prostate cancer health
disparity researcher
- PI or mentor must demonstrate a connection to, or effectiveness in working with, the affected population
or community
- Emphasis is on PI, mentor, and training program and environment
|
Predoctoral Ph.D. and M.D./Ph.D. PIs:
- Maximum funding of $92.5K for direct costs (plus 8% indirect costs)
- Period of performance cannot exceed 3 years
Postdoctoral Ph.D. PIs:
- Maximum of $115K for direct costs (plus 8% indirect costs)
- Period of performance cannot exceed 2 years
Postdoctoral Ph.D. PIs:
- Maximum of $60K per year for direct costs (plus 8% indirect costs)
- Period of performance cannot exceed 2 years
|
| Collaborative Undergraduate Historically Black Colleges and Universities (HBCU) Student Summer Training
Program Award |
Independent investigators at or above the level of Assistant Professor (or equivalent) with a proven record
in prostate cancer research and training |
- Supports new or existing summer prostate cancer training programs for undergraduate HBCU students at host institutions
- Must enroll a minimum of four undergraduate HBCU trainees per year
- Host institution must have a record of achievement in prostate cancer research and training
|
- Maximum funding of $185K for direct costs (plus 8% indirect costs)
- Period of performance cannot exceed 3 years
|
| Physician Research Training Award |
At the time of proposal submission, the PI must be either:
- A physician with clinical duties and/or responsibilities in the last year of an
accredited medical residency or medical fellowship program; or
- A physician within 3 years of first independent faculty appointment
|
- Supports training of physicians with clinical duties for careers in prostate cancer research
- PIs must have a mentor with an established research program in prostate cancer
- Emphasis is on PI, mentor, and training program and environment
- Institution must provide at least 40% protection of PI's time for research
- Emphasis is on PI, mentor, and training program and environment
- NEW FOR FY09 Applications must address one or more of the FY09 Focus Areas:
Imaging, Biomarkers, Therapy, Genetics, Tumor Biology, and Survivorship
|
- Maximum funding of $130K for direct costs per year (plus 8% indirect costs)
- Period of performance is 3 years minimum and 5 years maximum
|
| Prostate Cancer Training Award |
Predoctoral Ph.D. and M.D./Ph.D. PIs:
- Must be enrolled full-time in an accredited doctoral program and must have completed all predissertation
requirements by October 1, 2009
Postdoctoral Ph.D. PIs:
- Must have successfully defended a doctoral thesis by October 1, 2009; and
- Have 3 years or less of postdoctoral fellowship experience by October 1, 2009
Postdoctoral M.D. PIs:
- Must have an M.D.; and
- Must be able to devote at least 40% effort; and
- By August 1, 2009, must be:
- Enrolled in an accredited intern, residency, or fellowship training program,
or
- Within 3 years of the last formal training
|
- Supports prostate cancer research training for individuals in the early stages of their careers
- All PIs must have a designated mentor
- Emphasis is on PI, mentor, and training program and environment
|
Predoctoral Ph.D. and M.D./Ph.D. PIs:
- Maximum funding of $92.5K for direct costs (plus 8% indirect costs)
- Period of performance cannot exceed 3 years
Postdoctoral Ph.D. PIs:
- Maximum of $115K for direct costs (plus 8% indirect costs)
- Period of performance cannot exceed 2 years
Postdoctoral Ph.D. PIs:
- Maximum of $60K per year for direct costs (plus 8% indirect costs)
- Period of performance cannot exceed 2 years
|
